|
|||||
|
|
Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group |
|
| Authors: | Diekmann Kristin Kuzma-Kozakiewicz Magdalena Piotrkiewicz Maria Gromicho Marta Grosskreutz Julian Andersen Peter M. de Carvalho Mamede Uysal Hilmi Osmanovic Alma Schreiber-Katz Olivia Petri Susanne Körner Sonja |
| Affiliation: | 1.Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, C, Germany ;2.Department of Neurology, Medical University of Warsaw, Warsaw, Poland ;3.Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Warsaw, Poland ;4.Faculty of Medicine, Institute of Physiology-Instituto de Medicina Molecular, University of Lisbon, Lisbon, Portugal ;5.Department of Neurology, University Hospital Jena, Jena, Germany ;6.Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden ;7.Department of Neurology, Faculty of Medicine, Akdeniz University, Antalya, Turkey ;8.Center for Systems Neuroscience (ZSN), Hannover, Germany ; |
| Abstract: | Journal of Neurology - Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with loss of muscle function. The pathogenesis is still unclear and the heterogeneity of ALS... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |